Monthly Archives: February 2020

Kontrol Energy Adds New Director to Board

TORONTO, ON / ACCESSWIRE / February 20, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) ("Kontrol" or "Company") a leader in the energy efficiency sector through IoT, Cloud and SaaS technology is pleased to announce that Joanna Osawe has been appointed to its Board of Directors.

Joanna Osawe is the Chair, President & CEO of Women in Renewable Energy (WiRE), a group which encourages and supports women to enter the renewable energy industry. WiRE is inclusive and educates on all renewable and emerging energy technologies with chapters in St. John's, Halifax, Montreal, Ottawa, Toronto, Mississauga, Windsor, Calgary, Edmonton, Saskatchewan and Vancouver and Kamloops. WiRE has expanded with its 1st International Launch in Istanbul, Turkey with the Canadian Embassy and as of 2019 WiRE has expanded to Tbilisi Georgia, Baku Azerbaijan and Amman Jordan. WiRE is expanding in the MENA regions currently. WiRE regularly organizes educational field trips, monthly networking meetings, an awards recognition program, student mentoring and bursaries, communications and engagement initiatives. Joanna also works at DMC Power as the Global Business Development Manager, Major Projects.

Joanna studied languages at Western University, graduating with an Honours BA. Joanna has used her language skills on a focused, 15+ year management career at leading renewable and energy sector companies in Canada and the United States. By carrying complex projects through many stages, she has seen firsthand the vital role renewable energy and emerging technologies serve in moving the Canadian, American and Global energy mix forward.

"We are very pleased that Joanna has joined the Kontrol Board of Directors. Joanna has extensive experience in the alternative energy markets and a global reach through her fantastic work through Women in Renewable Energy (WiRE)," stated Paul Ghezzi, CEO of Kontrol Energy.

Shares for Debt

The Company also announces that it has issued 173,586 common shares at a deemed price per share of $0.58 in settlement of $100,680 in outstanding debts (the "Transaction").

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency and smart building sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com



Contact us at admin@kontrolenergy.com Kontrol Energy Corp., 180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8 Tel: 905.766.0400, Toll free: 1.844.566.8123

For further information, contact:

Paul Ghezzi, Chief Executive Officer
paul@kontrolenergy.com
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information

Certain information included in this press release, including information relating to future financial or operating performance and other statements that express the expectations of management or estimates of future performance constitute "forward-looking statements". Such forward-looking statements include, without limitation, statements regarding possible future acquisitions, organic growth, the provision of solutions to customers and Greenhouse Gas emissions reductions, proposed financial savings and sustainable energy benefits and energy monitoring. Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief are based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that suitable businesses and technologies for acquisition and/or investment will be available, that such acquisitions and or investment transactions will be concluded, that sufficient capital will be available to the Company, that technology will be as effective as anticipated, that organic growth will occur, and others. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Such risks include, but are not limited to, lack of acquisition and investment opportunities or that such opportunities may not be concluded on reasonable terms, or at all, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company's product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and the Company does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise, except as required under applicable securities law.

SOURCE: Kontrol Energy Corp.

ReleaseID: 577115

Organto Announces Record Fourth Quarter and Fiscal 2019 Revenues

Announces Investor Update Call for Monday, February 24th at 11:00 am EST

VANCOUVER, BC / ACCESSWIRE / February 20, 2020 / Organto Foods Inc. (TSXV:OGO)(OTC:OGOFF) ("Organto" or "the Company"), an integrated provider of fresh organic vegetables and fruits today announced expected record revenues for the fourth quarter and fiscal year ended December 31, 2019. In addition, Organto announced it will be hosting an investor call on Monday, February 24, 2020 at 11:00 am EST, to update on current market conditions, ongoing operations and plans for the future.

Fourth Quarter 2019 Revenue Guidance

The quarter ended December 31, 2019 saw record fourth quarter revenues of approximately CDN $1.5 to CDN $1.6 million, an increase of approximately 45% versus the same quarter in the prior year. Fourth quarter revenues were driven by sales of organic asparagus, avocado, mangos and other fruits and vegetables, which were sold to a diverse customer base of traditional retailers, specialty organic retailers, food service and distributors located in the Netherlands, U.K., Germany, France, Spain, Russia, Sweden, Norway and Denmark. Gross margins are expected to be significantly improved versus the prior year, as a result of Organto's reengineered business model.

"We are very pleased with our projected record fourth quarter revenues which reflect the efforts we have made to reposition our business in the fast-growing fresh organic vegetables and fruits category. We believe the opportunity in organic vegetables and fruits is very strong as the global trend towards healthy eating and wellness continues to drive growing demand on a global basis." commented Rients van der Wal, Chief Operating Officer of Organto and CEO of Organto Europe B.V. "We continue to build out our operating platform and expand our customer base as we add new supply sources to meet market demands, and as a result, we believe we are well-positioned to take advantage of the growing health and wellness opportunity." added Mr. Van der Wal.

Fiscal 2019 Revenue Guidance

Revenues for the year ended December 31, 2019 will also be an annual revenue record for Organto with revenues expected in the range of approximately CDN $3.65 to CDN $3.75 million1, an increase of approximately 140% versus the prior year. The majority of revenues in fiscal 2019 were realized in the last two quarters of the year as the Company's repositioned business model gained traction in the third quarter, leading to increases in both revenue and margins. Gross margins are expected to be approximately 6% for Fiscal 2019 versus -38% for Fiscal 2018 as our business continued to grow in the back half of the year.

1 Forecast is based on shipping a variety of organic and conventional products including avocados, berries, asparagus and other products with an average sales price ranging from CDN$4-$11/kilo of sold product. We anticipate sourcing products from numerous suppliers and countries including, but not limited to, México, Perú, Argentina, Zimbabwe and other countries.

Over the past eighteen months, Organto has repositioned its organic foods platform shifting from an asset heavy, single revenue stream business model, to an asset light, multi-stream business model. The Company has made important progress in executing its plans including exiting Company-owned growing operations, selling its processing facilities in Guatemala and exiting Company operated packaging operations in the Netherlands, all in favor of strategic sourcing arrangements with grower partners in Peru, Argentina, Colombia, Morocco, Mexico, Zimbabwe and others and third party processing and packaging arrangements with globally positioned strategic partners. Organto has also streamlined its cost base and expanded its product offering from high-value organic vegetables including organic green beans, sugar snaps and snow peas to other value-added organic and conventional vegetables and fruits including asparagus, avocado, blueberries, mango and other products. Organto continues to pursue new strategic supply sources around the globe as it works to complete year-round supply of its core product offerings and also bring new complimentary products to its existing portfolio.

Investor Update Call – Monday, February 24, 2020 at 11:00 AM EST

Organto plans to host a conference call at 11:00 AM EST on Monday, February 24, 2020 to discuss current market conditions, ongoing operations and plans for the future. After opening remarks there will be a question and answer period. This call may be accessed through one of the following numbers:

U.S.: +1 929 436 2866
U.K.: +44 203 481 5237
Germany: +49 695 050 2596

Canada: +1 647 558 0588
Netherlands: +31 20 794 0854

Please enter the following Meeting ID#459706742. Alternatively, you can enter the Zoom portal by the following link at https://zoom.us/j/459706742.

ON BEHALF OF THE BOARD,

Steve Bromley
Chair and Interim Chief Executive Officer

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

For more information contact:

Investor Relations
604-634-0970
1-888-818-1364
info@organto.com

ABOUT ORGANTO

Organto's business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people and its shareholders. The Organto Foods Group is an integrated provider of year-round value-added branded organic vegetables and seasonal organic and non-GMO fruit and vegetable products using an asset-light business model to serve a growing socially responsible and health conscious consumer around the globe.

FORWARD LOOKING STATEMENTS

This news release may include certain forward-looking information and statements, as defined by law including without limitation Canadian securities laws and the "safe harbor" provisions of the US Private Securities Litigation Reform Act of 1995 ("forward-looking statements"). In particular, and without limitation, this news release contains forward-looking statements respecting Organto's business model and markets; Organto's integrated supply capabilities and plans to continue to develop and expand these capabilities; Organto's belief that the opportunity in organic vegetables and fruits is very strong as healthy eating and wellness grows on a global basis; Organto's belief that as a result of repositioning the Company is well-positioned to capture the growing markets opportunity; Organto's expectation that revenues in the fourth quarter will be in the range of CDN $1.5 to CDN $1.6 million, representing a fourth quarter revenue record for the Company; Organto's expectation that revenues for fiscal 2019 will be in the range of CDN $3.65 to CDN $3.75 million, representing an annual revenue record for the Company; Organto's expectation that gross margins for the fourth quarter will be significantly improved versus the prior year; management's beliefs, assumptions and expectations; and general business and economic conditions. Forward-looking statements are based on a number of assumptions that may prove to be incorrect, including without limitation assumptions about the following: the ability and time frame within which Organto's business model will be implemented and product supply will be increased; cost increases; dependence on suppliers, partners and contractual counter-parties; changes in the business or prospects of Organto; unforeseen circumstances; risks associated with the organic produce business generally, including inclement weather, unfavorable growing conditions, low crop yields, variations in crop quality, spoilage, import and export laws and similar risks; transportation costs and risks; general business and economic conditions; and ongoing relations with distributors, customers, employees, suppliers, consultants, contractors and partners. The foregoing list is not exhaustive and Organto undertakes no obligation to update any of the foregoing except as required by law.

SOURCE: Organto Foods Inc.

ReleaseID: 577099

North Carolina Football Club to Host Preseason Media Luncheon at One Glenwood Along with Issuer Direct

RALEIGH, NC / ACCESSWIRE / February 20, 2020 / In conjunction with club partner Issuer Direct, North Carolina Football Club will host its preseason media luncheon at the One Glenwood building in downtown Raleigh on Glenwood Avenue on Thursday, Feb. 27 at 12 p.m.

The event – open only to members of the press and invited guests – will include interviews with NCFC head coach Dave Sarachan and select players ahead of the upcoming USL Championship season. The team will also unveil its 2020 uniforms and front-of-jersey sponsor, and North Carolina Football Club Owner Steve Malik will provide an update on the Downtown South project.

"We are excited about the upcoming season and being a part of helping North Carolina FC with their news dissemination through our ACCESSWIRE platform," Issuer Direct President and CEO Brian Balbirnie said.

Issuer Direct will broadcast an online stream of the event, giving viewers the opportunity to ask questions remotely. Click here to access the online stream of the event. In addition to Sarachan, NCFC players Nazmi Albadawi, Alex Tambakis, Conor Donovan, DJ Taylor and Steven Miller will answer questions.

"We appreciate Issuer Direct's enthusiasm in supporting our club and are thankful for the role they are playing in helping put on this exciting event," said Santiago Lucio, North Carolina Football Club Director of Corporate Sponsorships. "We look forward to continuing to work with Issuer Direct on future projects involving our two organizations."

Coming off a 16-win season that included a trip to the postseason and the third-best home record in the USL Championship, NCFC opens its regular season on Saturday, March 7 at 2:30 p.m. against Louisville City FC at Sahlen's Stadium at WakeMed Soccer Park.

SOURCE: North Carolina FC

ReleaseID: 577084

Akeneo Hires Adobe Veteran as VP of Strategy and Growth

Kristin Naragon to spearhead PXM leader's global expansion.

BOSTON, MA / ACCESSWIRE / February 20, 2020 / Akeneo, a global leader in Product Experience Management (PXM) solutions for corporate brands and retailers, today announced the appointment of enterprise software veteran Kristin W. Naragon as VP of strategy and growth. The former head of go-to-market strategy for Adobe's marketing automation offering, Naragon will report directly to Akeneo CEO, Fred de Gombert, using her extensive experience in the industry to accelerate both organic and inorganic global growth opportunities.

Naragon's addition to Akeneo's executive team comes amid a period of rapid global expansion following Akeneo's completion of a $46M strategic fundraising round in September 2019 and its being named a "Leader" in the 2019 IDC MarketScape on PIM. In addition to driving new business opportunities, Naragon will lead Akeneo's strategic growth programs, from product marketing to corporate development and partnership strategy. Naragon will also drive the adoption of new and existing product functionality including Franklin, Akeneo's AI-powered product data intelligence tool. Franklin automates the tedious process of product-information curation and enrichment, a common pain point for retailers and brands.

Prior to joining Akeneo, Naragon spent nearly 7 years at Adobe, leading go-to-market strategies, product marketing, and strategic channel partnership programs for a variety of high-growth business units. Before that, she was the strategic alliance manager at Neolane, the global conversational marketing provider acquired by Adobe in 2013.

"At Akeneo, our product offering, customers, and vast open source community allow us to set a new standard in product experience management for both B2B and B2C companies," said Naragon. "Digital transformation demands a clear focus on centralized, contextualized, and accessible product information. In my time at Adobe, I saw the power of investing in customer experience management, and the impact that product information can have in accelerating that transformation."

"Kristin is a highly consummate professional with an exceptional track record in driving business expansion, customer success, and strategic partnerships for high-growth enterprise software companies," said Fred de Gombert, Akeneo CEO. "Our whole team is very excited to have her join us as we bring Akeneo's #1 open-source enterprise PIM solution to even more enterprise clients, expand our partner programs, and accelerate market adoption of our groundbreaking offering."

About Us

About Akeneo:

Akeneo is a global leader in Product Experience Management (PXM) solutions that help merchants and brands deliver a compelling customer experience across all sales channels, including eCommerce, mobile, print, and retail points of sale. Akeneo's open-source enterprise PIM, and product data intelligence solutions, dramatically improve product data quality and accuracy while simplifying and accelerating product catalog management.

Leading global brands, including Sephora, Fossil, Shop.com, and Auchan trust Akeneo's solutions to scale and customize their omnichannel and cross-border commerce initiatives. Using Akeneo, brands and retailers can improve customer experience, increase sales, reduce time to market, go global, and boost team productivity.

Contact:

David Wamsley 
4152599104
dave@rosebudpr.io  

SOURCE: Akeneo

ReleaseID: 576548

Huawei Releases New 5G Products and Solutions, Poised to Bring New Value

LONDON, ENGLAND / ACCESSWIRE / February 20, 2020 / At the Huawei product and solution launch in London, Ryan Ding, Executive Director of the Board and President of Huawei's Carrier BG, delivered a keynote titled "5G, Bring New Value". Ding released Huawei's new 5G products and solutions and launched the 5G Partner Innovation Program. These efforts aim to build a thriving 5G ecosystem and make 5G a commercial success.

Ryan Ding delivering the keynote

5G has developed beyond imagination in terms of deployment, ecosystem, and experience, says Ding, and networks are the foundation for the 5G business. So far, Huawei has been awarded 91 commercial 5G contracts and shipped over 600,000 5G Massive MIMO Active Antenna Units (AAUs). As a leading global 5G supplier, Huawei is committed to developing the best end-to-end 5G solutions. These will include the industry's highest-performance 5G base station that supports all scenarios and the Blade AAU with the industry's highest level of integration. The Blade AAU can work under all sub-6 GHz frequency bands and support 2G, 3G, 4G, and 5G networks. This addresses the issue of limited space for antenna installation, and reduces the total cost of ownership (TCO) by over 30% when compared to existing solutions. Huawei is also the first vendor in the industry to provide industrial 5G modules for vertical applications.

With 4G, people can share their videos and voices. However, with the ultra-high bandwidth offered by 5G, people will be able to enjoy immersive AR and VR experiences, allowing them to convey their thoughts and feelings like never before. These amazing experiences will create incredible new value. As 5G enhanced mobile broadband (eMBB) matures, high-definition video services will drive the massive growth of 5G B2C services. 5G B2B services have also shown huge potential. Huawei and some operators have jointly released 5G white papers and explored B2B applications in order to drive 5G application in numerous industries. At the launch event, Ryan Ding showed the audience Huawei's recently-released live broadcast backpack. This backpack, embedded with a 5G module, makes live broadcasting far easier.

Ding emphasized that in the 4G era, virtually all operators provided the same network experience. However, in the 5G era, operators can provide differentiated experiences and charge users based on more metrics, including data volume, latency, bandwidth, and number of devices connected. This makes it possible to monetize 5G. It is critical that operators redefine their 5G business models now.

Huawei and its global partners have worked together on multiple 5G projects, covering many domains including new media, campus, healthcare, and education. At the event, Ryan Ding launched the 5G Partner Innovation Program, witnessed by many of Huawei's industry partners. Through this program, Huawei plans to invest US$20 million into innovative 5G applications over the next 5 years, contributing to a thriving 5G ecosystem and accelerating the commercial success of 5G.

About Huawei

Huawei is a leading global provider of information and communications technology (ICT) infrastructure and smart devices. With integrated solutions across four key domains – telecom networks, IT, smart devices, and cloud services – we are committed to bringing digital to every person, home and organization for a fully connected, intelligent world.

Huawei's end-to-end portfolio of products, solutions and services are both competitive and secure. Through open collaboration with ecosystem partners, we create lasting value for our customers, working to empower people, enrich home life, and inspire innovation in organizations of all shapes and sizes.

At Huawei, innovation focuses on customer needs. We invest heavily in basic research, concentrating on technological breakthroughs that drive the world forward. We have more than 188,000 employees by the end of 2018, and we operate in more than 170 countries and regions. Founded in 1987, Huawei is a private company fully owned by its employees.

For more information, please visit Huawei online at www.huawei.com or follow us on:

http://www.linkedin.com/company/Huawei

http://www.twitter.com/Huawei

http://www.facebook.com/Huawei

http://www.youtube.com/Huawei

Huawei contact:
Isabel Zhang
isabel.zhang@wmglobal.com

SOURCE: Huawei

ReleaseID: 577133

PowerBand and U.S. Financier Bryan Hunt Launch “Driveaway” App for Public To Sell Vehicles in The United States

VANCOUVER, BC / ACCESSWIRE / February 20, 2020 / PowerBand Solutions Inc. (TSXV:PBX) (OTCQB:PWWBF) (Frankfurt:1ZVA) ("PowerBand", "PBX" or the "Company") is pleased to announce its Driveaway consumer app for iOS devices has been approved for publication by Apple and is now available for download in the US App Store.

The Driveaway app introduces a new way for consumers to easily sell vehicles from their smart phone, tablet, or computer. Simply by uploading their vehicle information directly to the app, consumers instantly access a network of potential buyers. It is the latest advancement in the PowerBand consumer platform to revolutionize how vehicles are bought, sold, leased and traded around the globe.

The Driveaway app will initially be available to residents of Northwest Arkansas and, after feedback, will be expanded across Arkansas, Oklahoma and Texas. It will later be available in all of the United States and Canada. Consumers can also visit us at www.driveawaypro.com. An android version will also soon be available.

Built by PowerBand, the launch of the Driveaway app in the United States is being piloted by D2D Auto Auctions LLC ("D2D"). D2D is co-owned by PowerBand and Arkansas-based financier Bryan Hunt, Director of J.B Hunt Transport.

"This is a revolutionary advance that empowers people to easily sell and trade cars in the used car market," said PowerBand CEO Kelly Jennings. "People now have at their fingertips – whether it's on their smart phone, tablet or computer – a way to sell vehicles to a wide network of buyers. Our mission is to make selling a car as easy as using Amazon or ordering an Uber."

The Driveaway app is supported by D2D Auto Auctions, a network facilitating live vehicle auctions between dealers nationwide. D2D Auto Auctions' direct link to the new Driveaway app provides consumers the ability to secure live bids on their vehicle sale via 20-minute auctions, with participation from a network of dealer buyers.

"People deserve a fast, trustworthy, simple way to sell their cars and trucks," said Bryan Hunt. "A few swipes and clicks in the Driveaway app will instantly provide this opportunity to millions of Americans."

PowerBand, with its partners, is building a highly disruptive global transaction platform to transform the experience of buying, selling and leasing cars and trucks for millions of vehicle owners and automotive dealers. PowerBand is also in the process of securing multi-billion-dollar credit facilities to allow the purchase and leasing of vehicles on the PowerBand platform.

Recent company milestones include:

An agreement with RouteOne to put the PowerBand cloud-based platform in the hands of up to 18,000 automotive dealerships in the United States and Canada.
An agreement with Phoenix Capital to raise up to CDN250-million for its Canadian operations.
An agreement with Citation Capital, based in London, England, to assist in the raising of further credit facilities. Citation will use its proven, international network of financial channels to raise credit facilities for PowerBand operations in the U.S., European, Australian and Asian Markets.
PowerBand has strategically positioned itself in the U.S. automotive market, by acquiring a majority share of MUSA Auto Finance, LLC ("MUSA") in July, 2019. Founded in 2016, MUSA's innovative transaction platform modernized the new and pre-owned vehicle leasing experience, providing dealers and consumers with the most advanced leasing options in the industry. The technology takes applications, calculates leases, auto-decisions applications, provides approvals back to dealer partners and prefills lease contracts accurately. Approvals can occur in less than eight seconds. As a result of its proprietary technology, MUSA was awarded a contract by Tesla Motors to become a national leasing partner in 2018.

About PowerBand Solutions Inc.

PowerBand Solutions Inc. is a technology provider listed on the TSX Venture Exchange. The Company's cloud-based platform is revolutionizing how we buy, sell, lease, and auction vehicles. With the receipt of its exporter license and its acquisition of MUSA Auto Finance, the Company is well positioned to become a leader in the cross-border used vehicle export market, the used vehicle auction market, and the vehicle leasing market in the U.S. and Canada.

For further information, please contact:

Richard Goldman, VP Corporate Development
P: 1-866-768-7653
rgoldman@powerbandsolutions.com

FORWARD-LOOKING STATEMENTS

This news release contains forward-looking statements relating to the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding future plans and objectives of the Company, are forward looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. As a result, we cannot guarantee that any forward-looking statement will materialize and the reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as at the date of this news release, and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by Canadian securities law.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws, unless an exemption from such registration is available.

SOURCE: PowerBand Solutions Inc.

ReleaseID: 577102

DECN Announces Market Readiness of Its GenUltimate TBG, Adds To Product’s Compatibility at The Request Of Strategic Partner, Completes Its Universal Translator GenExpidient! Device

Company posts initial forecast for its new GenAccord!, moves two new products GenUltimate! precis TBG and GenCambre! into advanced development, readies patents for GenUltimate TBG & GenExpidient!

LOS ANGELES, CA / ACCESSWIRE / February 20, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) is an 18-year old, diabetes-focused bio-technology development firm, manufacturer, quality plan administrator, FDA registered medical device support organization, and exclusive worldwide sales and regulatory process agent for the GenUltimate! ("Sunshine") diabetes test strip, its GenAccord! systems for the uninsured and under-insured, its GenChoice! ("Ladybug") test strip now in the later stages of FDA 510(k) prosecution, its mate! GenUltimate Precis products manufactured for Eastern European International markets. The company also markets its PetSure! test strip for the diabetic testing of dogs and cats, a diagnostic specifically designed to run on the market leading Zoetis Alpha Trak meter system as well as the GenUltimate! 4Pets Test strip and Avantage! meter. Finally the company has certified as market ready its GenUltimate! TBG ("Dragonfly") diabetes testing system, and announces the completion of its Universal Translator device GenExpidient!, a device that serves as a universal translation device and dramatically speeds development of alternative test strips that will run on legacy systems.

The company also announced that with the completion of development of the GenExpiedient! Universal Translator, two products in development have been moved to Advanced Development (approx. 120 days to commercial viability), GenCambre! and the TBG version of GenUltimate! Precis TBG. Precis TBG will sell through our Russian Federation partner.

Keith Berman, CEO of Decision Diagnostics stated "Despite our limited resources, or perhaps because we have fewer resources, we have been able to channel our activities into products that can be introduced to the market quickly. In 2020 we will have introduced GenUltimate! TBG, GenAccord!, GenCambre! and now GenExpidient! "

Mr. Berman continued, "We have great hopes for GenExpidient! This device that will allow similar commercial systems with different glucometers and/or meters of different vintage to work with the same test strip of our development. This has brought another 6 legacy products into the realm of our brand. GenExpidient! is eminently patentable, and along with our GenUltimate TBG are the subject of three patent applications now underway."

Mr. Berman concluded, "We have posted our "cocktail napkin" forecast for our GenAccord! product line. We were a little late with this forecast, primarily because we have been granted additional territories and had to amend the forecast. The forecast will again be revised to take into account our new retail partner who has agreed to carry the GenAccord! line in over 2000 retail stores. One thing that can be said about this partner is that their clientel are fanatical about the brand name products sold at the 2000+ retail stores. Back to the forecast that is posted: for the most part, the forecast breaks down and displays by country. This forecast can be viewed at: http://decisiondiagnostics.co/docs/new/Exhibit%20D.pdf

A password to the file will be required. Shareholders and interested parties who wish to view the forecast can call the company and after being asked to answer a few questions, will be provided the password. The password is not "password." The forecast is viewable on Microsoft, Google, and Firefox browsers.

ABOUT DECISION DIAGNOSTICS CORP

Decision Diagnostics Corp. is the leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters. DECN's products are designed to operate efficiently and less expensively on certain glucose meters already in use by almost 7.5 million diabetics worldwide. With new inspired technology diabetic test strips already in the final stages of development, DECN products compete on a worldwide scale with legacy manufacturers currently selling to 71+ percent of a $15+ billion at-home testing market. The company's GenUltimate TBG product is not yet available for sale in the United States or Puerto Rico but is on sale Internationally. Our GenAccord! product has been launched Internationally.

Forward-Looking Statements:

This release contains the company's forward-looking statements which are based on management's current expectations and assumptions as of February 19, 2020 regarding the company's business and performance, its prospects, current factors, the economy, and other future conditions and forecasts of future events, circumstances, and results.

CONTACT INFORMATION:

Decision Diagnostics Corp.
Keith Berman (805) 446-2973

info@decisiondiagnostics.co
www.genultimate.com
www.genultimatetbg.com
www.petsureteststrips.com
www.pharmatechdirect.com

SOURCE: Decision Diagnostics Corp.

ReleaseID: 577069

ZoomAway’s Tripsee Generates Exponential Client Growth and Revenue Following Acquisition Announcement

VANCOUVER, BC / ACCESSWIRE / February 20, 2020 / ZoomAway Travel Inc.(US OTCQB:ZMWYF) (TSXV:ZMA) (the "Company" or "ZMA") www.zoomaway.com, is pleased to announce the significant milestones that have been achieved since their acquisition of Tripsee in late 2019. Travel, Concierge and Registration Management are combined to shape the Tripsee platform. The Retail Travel Website enables retail users to plan and book vacations via www.tripsee.travel. The Concierge Platform (www.tripsee.travel/concierge) will provide virtual concierge functionality for a diverse portfolio of hotels and resorts around the world. The Registration Management System targets larger groups, allowing for customizable web registration solutions, ticketing, and group-focused itinerary management.

Since the upgrade to the Tripsee platform since acquisition we can now announce Tripsee is generating revenue with the addition of several valued clients. These clients chose the Tripsee Concierge platform over other larger platforms, due to the depth of features included with Tripsee. The list of featured services the platform currently offers include:

Visual Itinerary Builder – Allows the concierge to visually build customized itineraries that can be sent to the mobile devices of all guests

Hotel Branded Kiosk – iPad application allows guests to view full details (pictures, opening hours, reviews, distances and much more) of restaurants, spas, attractions, and events occurring during your stay.

Recommendation Engine – Ability to send guest recommendations over SMS texts.

Guest Management System – An updated system allowing integrated information including name, email, phone, tags, notes, and stay history (check in, checkout and room number).

Guest Profile/Timeline – A guest history of past recommendations and activities with a timeline. The system builds a profile for each guest with their likes and preferences.

Task/To-do List – A simple task list that keeps track of tasks that the office staff or concierge needs to do.

Import/Export – With a few simple clicks staff can import existing guest data or export.

Package Tracking – Track packages from delivery all the way to the guest's room.

Hotel Messenger – Guests can message the front desk/concierge through SMS texts. Track and store all conversations for each guest with the messenger built-in notification system and forwarding. Includes 1500 SMS messages a month.

Automatic Messages – The system will send a welcome and check out message at specific times as well as out of office messages.

Bot/AI Messages- A system that will analyze the message and automatically reply. Currently we support, Wi-Fi, Breakfast, Room number, Lift status/Ski conditions, and weather.

In a recent interview, Sean Schaeffer, CEO of Zoomaway stated "We've spent the last couple of months really digging into the potential of this product and as I've said before, it's an impressive amount of tech spread out over three very distinct platforms, each with their own incredible revenue potential. I'm thrilled to be building an eager and ambitious sales team that can really take all of our products to market." Mr. Schaeffer continued "I understand that everyone's focus is perhaps directed towards ZoomedOUT, but I wanted to remind everyone that we have other products here that generate cash flow, have tremendous crossover potential with ZoomedOUT, and continue to improve the Company's bottom line."

For additional information contact: Sean Schaeffer, CEO, ZoomAway Travel Inc., at 775-691-8860, sean@zoomaway.com or stay up-to-date and sign up for our newsletter.

About Us

Zoomaway Travel Inc. is a technology company that is revolutionizing the Hospitality and Travel Industries. We have developed a variety of software solutions that enhance the planning and engagement of everyday tourists. Our flagship project, ZoomedOUT, is a complete modernization and re-imagination of mobile travel apps. In a full 3D environment, we are able to integrate planning, booking, social media, and camaraderie into a tangibly rewarding experience. We are combining Travel, Hospitality, Mobile Gaming and Augmented Reality to change the way users travel into 2020 and beyond. Additional information about ZoomAway Inc. can be found at www.zoomaway.com.

About Zero8 Studios, Inc.

Zero8 Studios, based in Reno, Nevada, specializes in new and innovative games and technology platforms. With a focus on social gaming and almost two decades of experience building countless game titles, gaming platforms, and various technologies. The Zero8 Studios' team has assisted dozens of AAA publishers, large clientele, manufacturers, and casinos in the design, production, and delivery of their products to players around the world. Additional information can be found at www.zero8studios.com.

Forward-Looking Statements

This release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include regulatory actions, market prices, and continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates, and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

Neither the TSX Venture Exchange nor it's Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed Offering and has neither approved nor disapproved the contents of this press release.

SOURCE: ZoomAway Travel Inc.

ReleaseID: 577118

Jaguar Health Subsidiary Napo Pharmaceuticals Wins 2019 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award

SAN FRANCISCO, CA / ACCESSWIRE / February 20, 2020 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"), today announced that the nonprofit American Botanical Council (ABC) has given the 2019 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award to the Company's wholly-owned subsidiary, Napo Pharmaceuticals, Inc. ("Napo") in recognition of Napo's ongoing commitment to the sustainable development and production of natural therapeutic preparations. Specifically, this award acknowledges the successful development and approval of crofelemer, which is derived from the medicinal Croton lechleri tree in the Amazon rainforest.

Crofelemer, the active ingredient in Mytesi®, the Company's FDA-approved prescription drug product, is a naturally derived new molecular entity extracted and purified from the red bark sap of the Croton lechleri tree. The Croton lechleri sap, commonly known as sangre de drago (which translates to "dragon's blood" in Spanish), has a long history of medicinal use by indigenous peoples.

"We are very grateful to the American Botanical Council for this recognition," stated Steven King, PhD, Jaguar Health's executive vice president of sustainable supply, ethnobotanical research and intellectual property. "We in turn would like to specifically acknowledge the intellectual contribution of local and indigenous peoples of the Northwest Amazon Basin for identifying the healing properties of traditional plant medicines. We would like to be sure that the international medical and patient community know that indigenous science and ethnomedical expertise continues to provide solutions to medical challenges for humans and animals."

Lisa Conte, Jaguar Health's president and CEO, commented, "We are delighted to receive this award that recognizes our focus on developing and commercializing novel, sustainably-derived therapeutics to enhance gastrointestinal health around the globe. We are also pleased to be among the distinguished group of past recipients that includes our esteemed partner, Indena."

Indena S.p.A., one of the world's largest producers of clinically-tested botanical extracts for the food, dietary supplement, cosmetic, and pharmaceutical markets, received the ABC Tyler award in 2008.

The ABC Tyler Award was created to honor one of the most respected U.S. scientists in late-20th century herbal medicine and pharmacognosy (the science that studies drugs of natural origin, usually from plants). Professor Varro E. Tyler, PhD was an early trustee of ABC, and vice-president of academic affairs and dean of the College of Pharmacy and Pharmaceutical Sciences at Purdue University. He was the senior author of six editions of the leading pharmacognosy textbook that was formerly used in every college of pharmacy in the United States, and numerous other professional and popular books and academic articles. Tyler encouraged scientific and product integrity, and envisioned a rational phytomedicinal health care sector that valued the proper evaluation of a phytomedicinal product's quality, safety, and efficacy.

ABC's founder and executive director Mark Blumenthal commented on this award: "During my 46-year career in the medicinal plant research and education community, Professor Varro Tyler was one of my prime mentors. He was strongly committed to the proposition that companies dealing with botanicals should invest some of their revenues into research on their phytomedicinal ingredients and products. I had the good fortune to accompany him on his two trips to the Peruvian Amazon in the 1990s for the ABC ‘Pharmacy from the Rainforest' Ethnobotany Ecotours, where we witnessed the traditional use of the red sangre de drago sap from the tree bark. With Napo Pharmaceuticals' sustainable development of the trees for harvesting the sap and their development of an FDA-approved drug from it, I firmly believe that if he were here today, Professor Tyler would fully support our choice of Napo Pharmaceuticals for this award in his name."

ABC chief science officer Stefan Gafner commented, "Napo Pharmaceuticals has not only compelling science, but also an exceptional track record with regards to its sustainability practices, e.g., its harvesting process, initiatives to conserve the environment in which the Croton lechleri trees grow, and benefit-sharing strategy with the countries and cultural groups with which it collaborates. In my opinion, this company is a role model for the entire botanical drug and dietary supplement industry."

Previous recipients of the ABC Tyler Award include GW Pharmaceuticals (2018); Pharmatoka (2017); Brassica Protection Products (2016); MediHerb/Integria Healthcare (2015); SFI Flordis International (2014); Wakunaga Pharmaceutical Company (2013); Horphag Research (2012); Bioforce (2011); New Chapter (2010); Bionorica (2009); Indena (2008); and Dr. Willmar Schwabe Pharmaceuticals (2007).

The award will be presented at the 15th Annual ABC Botanical Celebration and Awards Ceremony on March 4, 2020, in Anaheim, California. The event, open for ABC Sponsor Members, occurs during Natural Products Expo West.

About the American Botanical Council

Established in 1988, the American Botanical Council (ABC) is the leading independent, nonprofit, international member-based organization providing education using science-based and traditional information to promote the responsible use of herbal medicine. ABC serves the public, researchers, educators, healthcare professionals, industry and media, and has been a highly respected source and an innovative force for many years.

About Jaguar Health, Inc.

Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

For more information about Jaguar, please visit jaguar.health. For more information about Napo, visit napopharma.com.

About Mytesi®

Mytesi (crofelemer) is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART). Mytesi is not indicated for the treatment of infectious diarrhea. Rule out infectious etiologies of diarrhea before starting Mytesi. If infectious etiologies are not considered, there is a risk that patients with infectious etiologies will not receive the appropriate therapy and their disease may worsen. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (5.7%), bronchitis (3.9%), cough (3.5%), flatulence (3.1%), and increased bilirubin (3.1%).

See full Prescribing Information at Mytesi.com. Crofelemer, the active ingredient in Mytesi, is a botanical (plant-based) drug extracted and purified from the red bark sap of the medicinal Croton lechleri tree in the Amazon rainforest. Napo has established a sustainable harvesting program for crofelemer to ensure a high degree of quality and ecological integrity.

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements." These include statements regarding the expectation that the award will be presented at the 15th Annual ABC Botanical Celebration and Awards Ceremony on March 4, 2020, in Anaheim, California. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Some of the factors that could affect our actual results are included in the periodic reports on Form 10-K and Form 10-Q that we file with the Securities and Exchange Commission. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contact:

Peter Hodge
Jaguar Health, Inc.
phodge@jaguar.health
Jaguar-JAGX

SOURCE: Jaguar Health, Inc.

ReleaseID: 576841

MoSys, Inc. Reports Fourth Quarter 2019 Financial Results

Fourth Quarter Revenue Exceeds Guidance

SAN JOSE, CA / ACCESSWIRE / February 20, 2020 / MoSys, Inc. (NASDAQ:MOSY), a provider of high-speed semiconductor solutions, today reported financial results for the fourth quarter and fiscal year ended December 31, 2019.

Fourth Quarter 2019 Financial Results

Total net revenue for the fourth quarter of 2019 was $2.3 million, compared with $1.2 million for the previous quarter and $3.5 million for the fourth quarter of 2018. Product revenue for the fourth quarter was $2.1 million, compared with $1.0 million in the third quarter of 2019 and $3.2 million in the year ago period. The sequential increase in product revenue reflected increased shipments of our Bandwidth Engine® products.

GAAP gross margin for the fourth quarter of 2019 was 59%, compared with 66% for the third quarter of 2019 and 72% for the fourth quarter of 2018. Fourth quarter gross margin was negatively impacted by unfavorable manufacturing variances; however, the Company expects gross margin improvement in the first half of 2020.

Total operating expenses on a GAAP basis for the fourth quarter of 2019 were $2.0 million, compared with operating expenses of $2.6 million in the previous quarter, which included a goodwill impairment charge of $0.4 million, and $11.7 million in the fourth quarter of 2018, which included a goodwill impairment charge of $9.7 million. Total non-GAAP operating expenses, excluding stock-based compensation expenses, impairment of goodwill and amortization of intangible assets, for the fourth quarter of 2019 were $1.9 million, compared with $2.1 million in the third quarter of 2019 and $1.7 million in the fourth quarter of 2018.

In August 2019, the Company effected a 1-for-20 reverse stock split of its common stock. All share and per share amounts in this press release have been retroactively adjusted to reflect the reverse stock split for all current and prior periods.

GAAP net loss for the fourth quarter of 2019 was $0.7 million, or ($0.31) per share, compared with a net loss of $1.8 million, or ($0.83) per share, for the previous quarter and a net loss of $9.3 million, or ($5.04) per share, for the fourth quarter of 2018.

Non-GAAP net loss for the fourth quarter of 2019 was $0.6 million, or ($0.29) per share, compared with non-GAAP net loss of $1.3 million, or ($0.60) per share, in the prior quarter and non-GAAP net income of $0.7 million, or $0.28 per diluted share, in the fourth quarter of 2018. Adjusted EBITDA for the fourth quarter of 2019 was a negative $0.5 million, compared with a negative $1.2 million for the previous quarter and a positive $0.9 million for the fourth quarter of 2018. A reconciliation of GAAP results to non-GAAP results is provided in the financial statement tables following the text of this press release.

Management Commentary

"We are pleased with the increase in our fourth quarter product sales, with product revenues doubling sequentially driven by increased demand from our Bandwidth Engine customers," commented Dan Lewis, president and chief executive officer. "Most notably, we resumed shipments to a large security customer, which extended its requirements for our Bandwidth Engine 2 products. We also fulfilled significant Bandwidth Engine 3 orders from a lead customer during the quarter.

"From a product development perspective, we continue to leverage our current technologies and core competencies to expand our product offerings without incurring significant additional R&D expenses. An example is our new Software Acceleration Product Line. We recently announced the first product available for licensing from this family, our Packet Classification Platform, which utilizes our innovative virtual accelerator, the Graph Memory Engine (GME). The GME architecture allows for flexible implementation of acceleration algorithms in software with the ability to significantly scale performance by leveraging an FPGA combined with a MoSys Bandwidth Engine or Programmable HyperSpeed Engine IC. At a recent developer forum, we demonstrated the packet classification application using our GME on an integrated Xilinx UltraScale+ FPGA and Bandwidth Engine platform."

Mr. Lewis concluded, "We remain focused on expanding our IC customer base and identifying license opportunities for our new software acceleration products with our existing customers, as well as with newly cultivated relationships in additional market segments. We have expanded our sales channels in Europe and in North America, which has generated new opportunities for both product lines, and we expect to announce an additional sales initiative during the first quarter of 2020. Overall, the Company remains well positioned with lead customers in networking, test and measurement and application delivery, where we continued to secure new design wins during 2019. We have good visibility for the first half of 2020, and we intend to continue to closely manage our expenditures in order to minimize cash burn, as we execute our business plan and expand our sales opportunities in the coming year."

Business Outlook

The Company expects total net revenue for the first quarter of 2020 to be in the range of $1.7 million to $2.0 million.

Use of Non-GAAP Financial Measures

To supplement MoSys' consolidated financial statements presented in accordance with GAAP, MoSys uses non-GAAP financial measures that exclude from the statement of operations the effects of stock-based compensation, impairment of goodwill and intangible asset amortization. MoSys' management believes that the presentation of these non-GAAP financial measures is useful to investors and other interested persons because they are one of the primary indicators that MoSys' management uses for planning and forecasting future performance. The press release also makes reference to and reconciles GAAP net income (loss) and adjusted EBITDA, which the Company defines as GAAP net income (loss) before interest expense, income tax provision, and depreciation and amortization, as well as stock-based compensation, impairment of goodwill and intangible asset amortization. Management believes that the presentation of non-GAAP financial measures that exclude these items is useful to investors because management does not consider these charges part of the day-to-day business or reflective of the core operational activities of the Company that are within the control of management or that would be used to evaluate management's operating performance.

Investors are encouraged to review the reconciliations of these non-GAAP financial measures to the comparable GAAP results, which are provided in tables below the Condensed Consolidated Statements of Operations. The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements should be carefully evaluated. The non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. For additional information regarding these non-GAAP financial measures, and management's explanation of why it considers such measures to be useful, refer to the Form 8-K dated February 20, 2020 that the Company filed with the Securities and Exchange Commission.

Forward-Looking Statements

This press release may contain forward-looking statements about the Company, including, without limitation, its expected gross margin improvement in the first half of 2020, its anticipated total net revenue for the first quarter of 2020, anticipated benefits and performance expected from its IC products, the Company's future markets and future business prospects and its intention to continue to closely manage its expenditures in order to minimize cash burn. Forward-looking statements are based on certain assumptions and expectations of future events that are subject to risks and uncertainties. Actual results and trends may differ materially from historical results or those projected in any such forward-looking statements depending on a variety of factors. These factors include, but are not limited, to the following:

a lack of working capital to aggressively fund product development and growth;
the timing of customer orders and product shipments;
customer concentration;
lengthy sales cycle;
ability to enhance our existing proprietary technologies and develop new technologies;
achieving additional design wins for our IC products through the acceptance and adoption of our IC architecture and interface protocols by potential customers and their suppliers;
difficulties and delays in the development, production, testing and marketing of our ICs;
reliance on our manufacturing partners to assist successfully with the fabrication of our ICs;
availability of quantities of ICs supplied by our manufacturing partners at a competitive cost;
ability to make our new software acceleration and IP products commercially available and achieve customer acceptance of these new proprietary technologies;
level of intellectual property protection provided by our patents, the expenses and other consequences of litigation, including intellectual property infringement litigation, to which we may be or may become a party from time to time;
vigor and growth of markets served by our customers and our operations; and

other risks identified in the company's most recent report on Form 10-K filed with the Securities and Exchange Commission, as well as other reports that MoSys files from time to time with the Securities and Exchange Commission. MoSys undertakes no obligation to update publicly any forward-looking statement for any reason, except as required by law, even as new information becomes available or other events occur in the future.

About MoSys, Inc.

MoSys, Inc. (NASDAQ: MOSY) is a provider of semiconductor solutions that enable fast, intelligent data access for cloud networking, security, test and video systems. The company's solutions eliminate data access bottlenecks to deliver speed and intelligence for line cards and systems scaling from 100G to multi-terabits per second. Engineered and built for high-reliability carrier and enterprise applications, MoSys' Accelerator Engine IC product family is based on the company's patented high-performance, high-density random-access memory and its highly efficient, high-speed GigaChip™ serial-interface technology, and incorporates powerful application accelerating in-memory compute functions. More information is available at: www.mosys.com.

Bandwidth Engine and MoSys are registered trademarks of MoSys, Inc. in the US and/or other countries. The MoSys logo and GigaChip are trademarks of MoSys, Inc. All other marks mentioned herein are the property of their respective owners.

(Financial Tables to Follow)

Contact:

Jim Sullivan, CFO
MoSys, Inc.
+1 (408) 418-7500
jsullivan@mosys.com

MOSYS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts; unaudited)

 

 
Three Months Ended
 
 
Twelve Months Ended
 

 

 
December 31,
 
 
December 31,
 

 

 
2019
 
 
2018
 
 
2019
 
 
2018
 

 

 
 
 
 
 
 
 
 
 
 
 
 

Net Revenue

 
 
 
 
 
 
 
 
 
 
 
 

Product

 

2,144
 
 

3,242
 
 

9,377
 
 

15,053
 

Royalty and other

 
 
150
 
 
 
209
 
 
 
709
 
 
 
1,547
 

Total net revenue

 
 
2,294
 
 
 
3,451
 
 
 
10,086
 
 
 
16,600
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Cost of Net Revenue

 
 
942
 
 
 
964
 
 
 
3,931
 
 
 
6,346
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Gross Profit

 
 
1,352
 
 
 
2,487
 
 
 
6,155
 
 
 
10,254
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Operating Expenses

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Research and development

 
 
951
 
 
 
1,065
 
 
 
4,182
 
 
 
4,129
 

Selling, general and administrative

 
 
1,053
 
 
 
937
 
 
 
4,016
 
 
 
4,095
 

Impairment of goodwill

 
 

 
 
 
9,697
 
 
 
420
 
 
 
12,856
 

Total operating expenses

 
 
2,004
 
 
 
11,699
 
 
 
8,618
 
 
 
21,080
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Loss from operations

 
 
(652
)
 
 
(9,212
)
 
 
(2,463
)
 
 
(10,826
)

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Other expense, net

 
 
(34
)
 
 
(48
)
 
 
(117
)
 
 
(583
)

Net Loss

 

(686
)
 

(9,260
)
 

(2,580
)
 

(11,409
)

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Net loss per share

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Basic and diluted

 

(0.31
)
 

(5.04
)
 

(1.19
)
 

(14.82
)

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Shares used in computing net loss per share

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Basic and diluted

 
 
2,178
 
 
 
1,839
 
 
 
2,165
 
 
 
770
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

MOSYS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)

 
 
December
 

 

 
2019
 
 
2018
 

 

 
 
 
 
 
 

Assets

 
 
 
 
 
 

Current assets:

 
 
 
 
 
 

Cash, cash equivalents and investments

 

6,353
 
 

7,104
 

Accounts receivable, net

 
 
1,175
 
 
 
1,622
 

Inventories

 
 
968
 
 
 
1,148
 

Prepaid expenses and other

 
 
472
 
 
 
923
 

Total current assets

 
 
8,968
 
 
 
10,797
 

 

 
 
 
 
 
 
 
 

Property and equipment, net

 
 
197
 
 
 
279
 

Goodwill

 
 

 
 
 
420
 

Other

 
 
234
 
 
 
260
 

Total assets

 

9,399
 
 

11,756
 

 

 
 
 
 
 
 
 
 

Liabilities and Stockholders' Equity

 
 
 
 
 
 
 
 

Current liabilities:

 
 
 
 
 
 
 
 

Accounts payable

 

218
 
 

236
 

Deferred revenue

 
 
166
 
 
 
273
 

Accrued expenses and other

 
 
1,321
 
 
 
1,402
 

Total current liabilities

 
 
1,705
 
 
 
1,911
 

 

 
 
 
 
 
 
 
 

Convertible notes payable

 
 
2,858
 
 
 
2,671
 

Other long-term liabilities

 
 

 
 
 
17
 

Total liabilities

 
 
4,563
 
 
 
4,599
 

 

 
 
 
 
 
 
 
 

Stockholders' equity

 
 
4,836
 
 
 
7,157
 

 

 
 
 
 
 
 
 
 

Total liabilities and stockholders' equity

 

9,399
 
 

11,756
 

 

 
 
 
 
 
 
 
 

MOSYS, INC.
Reconciliation of GAAP to Non-GAAP Net Income (Loss) and Net Income (Loss) Per Share
(In thousands, except per share amounts; unaudited)

 

 
Three Months Ended
 
 
Twelve Months Ended
 

 

 
December 31,
 
 
December 31,
 

 

 
2019
 
 
2018
 
 
2019
 
 
2018
 

 

 
 
 
 
 
 
 
 
 
 
 
 

GAAP net loss

 

(686
)
 

(9,260
)
 

(2,580
)
 

(11,409
)

Stock-based compensation expense

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

-Research and development

 
 
27
 
 
 
132
 
 
 
108
 
 
 
327
 

-Selling, general and administrative

 
 
37
 
 
 
96
 
 
 
155
 
 
 
347
 

Total stock-based compensation expense

 
 
64
 
 
 
228
 
 
 
263
 
 
 
674
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Impairment of goodwill

 
 

 
 
 
9,697
 
 
 
420
 
 
 
12,856
 

Amortization of intangible assets

 
 

 
 
 
28
 
 
 

 
 
 
111
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Non-GAAP net income (loss)

 

(622
)
 

693
 
 

(1,897
)
 

2,232
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

GAAP net loss per share, basic

 

(0.31
)
 

(5.04
)
 

(1.19
)
 

(14.82
)

Reconciling items

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

-Stock-based compensation expense

 
 
0.02
 
 
 
0.13
 
 
 
0.12
 
 
 
0.88
 

-Impairment of goodwill

 
 

 
 
 
5.27
 
 
 
0.19
 
 
 
16.70
 

-Amortization of intangible assets

 
 

 
 
 
0.02
 
 
 

 
 
 
0.14
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Non-GAAP net income (loss) per share, basic

 

(0.29
)
 

0.38
 
 

(0.88
)
 

2.90
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

GAAP net loss per share, diluted

 

(0.31
)
 

(3.74
)
 

(1.19
)
 

(13.01
)

Reconciling items

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

-Stock-based compensation expense

 
 
0.02
 
 
 
0.09
 
 
 
0.12
 
 
 
0.77
 

-Impairment of goodwill

 
 

 
 
 
3.92
 
 
 
0.19
 
 
 
14.66
 

-Amortization of intangible assets

 
 

 
 
 
0.01
 
 
 

 
 
 
0.13
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Non-GAAP net income (loss) per share, diluted

 

(0.29
)
 

0.28
 
 

(0.88
)
 

2.55
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Basic

 
 
2,178
 
 
 
1,839
 
 
 
2,165
 
 
 
770
 

Diluted

 
 
2,178
 
 
 
2,472
 
 
 
2,165
 
 
 
877
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

MOSYS, INC.
Reconciliation of GAAP and Non-GAAP Financial Information
(In thousands; unaudited)

 

 
Three Months Ended
 
 
Twelve Months Ended
 

 

 
December 31,
 
 
December 31,
 

 

 
2019
 
 
2018
 
 
2019
 
 
2018
 

Reconciliation of GAAP net loss and

adjusted EBITDA

 
 
 
 
 
 
 
 
 
 
 
 

GAAP net loss

 

(686
)
 

(9,260
)
 

(2,580
)
 

(11,409
)

Stock-based compensation expense

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Research and development

 
 
27
 
 
 
132
 
 
 
108
 
 
 
327
 

Selling, general and administrative

 
 
37
 
 
 
96
 
 
 
155
 
 
 
347
 

Stock-based compensation expense

 
 
64
 
 
 
228
 
 
 
263
 
 
 
674
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Impairment of goodwill

 
 

 
 
 
9,697
 
 
 
420
 
 
 
12,856
 

Amortization of intangible assets

 
 

 
 
 
28
 
 
 

 
 
 
111
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Non-GAAP net income (loss)

 
 
(622
)
 
 
693
 
 
 
(1,897
)
 
 
2,232
 

EBITDA adjustments:

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Depreciation

 
 
37
 
 
 
112
 
 
 
185
 
 
 
598
 

Interest expense

 
 
56
 
 
 
51
 
 
 
220
 
 
 
582
 

Provision for income taxes

 
 

 
 
 
9
 
 
 

 
 
 
13
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Adjusted EBITDA

 

(529
)
 

865
 
 

(1,492
)
 

3,425
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

SOURCE: MoSys, Inc.

ReleaseID: 577112